e-learning
resources
Virtual 2021
07.09.2021
Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients
N. Dalil Roofchayee (Tehran, Islamic Republic of Iran), M. Marjani (Tehran, Islamic Republic of Iran), N. K.Dezfuli (Tehran, Islamic Republic of Iran), E. Mortaz (Tehran, Islamic Republic of Iran)
Source:
Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Session:
Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Session type:
E-poster
Number:
3089
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Dalil Roofchayee (Tehran, Islamic Republic of Iran), M. Marjani (Tehran, Islamic Republic of Iran), N. K.Dezfuli (Tehran, Islamic Republic of Iran), E. Mortaz (Tehran, Islamic Republic of Iran). T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients. 3089
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Evaluation of Th9 and Th22 cells within pleural effusions of tuberculosis and non-tuberculosis patients
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Immune responses in the lungs of patients with tuberculous pleural effusion without parenchymal tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Analysis of T-cell subsets in patients with tuberculous pleural effusions
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005
Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 467s
Year: 2004
Interleukin-16 in tuberculous and malignant pleural effusions
Source: Eur Respir J 2005; 25: 605-611
Year: 2005
Evaluation of inflammatory mediators of pleural effusion in tuberculosis and non-tuberculosis patients
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Pleural effusion: TB and not TB
Source: Annual Congress 2006 - MP12 - Pleural effusion: TB and not TB
Year: 2006
Utility of significant number of mesothelial cells in tuberculous pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 426s
Year: 2004
Flowcytometric analysis of peripheral blood & pleural fluid lymphocyte subpopulat in tuberculosis pleuritis and malignant pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 63s
Year: 2003
Pleural effusion in patients with IgG4-related disease: Investigated features and compared to tuberculous pleurisy
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
Thoracoscopy in tuberculous pleural effusions
Source: Annual Congress 2007 - Difficult tuberculosis cases II
Year: 2007
Adenosine deaminase (ADA) in diagnosis of tuberculous pleural effusions in a developing country and region with average incidence of pulmonary tuberculosis
Source: Annual Congress 2007 - Immunology and genetics of tuberculosis
Year: 2007
Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Chemokine characterisation of IFN-γ-deficient pleural effusions from patients with pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 556s
Year: 2002
Bactec
versus
histopathology in the clinical diagnosis of tuberculous pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 472s
Year: 2001
A rare cause of bilateral pleural effusion: tuberculous spondylodiscitis
Source: Annual Congress 2007 - Difficult tuberculosis cases II
Year: 2007
Does the age affect the diagnostic yield of different biomarkers in differentiation between tuberculous and non-tuberculous pleural effusions?
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept